v3.26.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2024 $ 35 $ 356,216 $ 1,146 $ (242,805) $ 114,592
Beginning balance (in shares) at Dec. 31, 2024 35,098,493        
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of stock options   11     11
Issuance of common stock upon exercise of stock options (in shares) 8,266        
Stock-based compensation expense   2,365     2,365
Vesting of restricted stock units $ 1       1
Vesting of restricted stock units (in shares) 632,797        
Net Income (Loss)       43,603 43,603
Foreign currency translation adjustments     (7)   (7)
Foreign currency translation adjustments reclassed out of accumulated other comprehensive income related to discontinued operations     (1,125)   (1,125)
Unrealized loss on marketable securities     (16)   (16)
Ending balance at Mar. 31, 2025 $ 36 358,592 (2) (199,202) 159,424
Ending balance (in shares) at Mar. 31, 2025 35,739,556        
Beginning balance at Dec. 31, 2025 $ 36 366,925 54 (223,316) 143,699
Beginning balance (in shares) at Dec. 31, 2025 36,321,866        
Increase (Decrease) in Stockholders' Equity          
Issuance of common stock upon exercise of stock options   80     80
Issuance of common stock upon exercise of stock options (in shares) 53,195        
Stock-based compensation expense   2,399     2,399
Vesting of restricted stock units $ 1 (1)      
Vesting of restricted stock units (in shares) 1,038,792        
Net Income (Loss)       (11,955) (11,955)
Unrealized loss on marketable securities     (52)   (52)
Ending balance at Mar. 31, 2026 $ 37 $ 369,403 $ 2 $ (235,271) $ 134,171
Ending balance (in shares) at Mar. 31, 2026 37,413,853